Objective: To study the mutation spectrum and phenotype-genotype correlation of Darier disease (DD) in Tunisian patients.
D
ARIER DISEASE (DD; MIM 124200) is a rare dominantly inherited disorder that predominantly affects the skin. 1 It is characterized by warty papules and plaques in seborrheic areas, palmoplantar pits, and distinctive nail dystrophy. 2 The DD locus has been mapped to chromosome 12q23-24.1; mutations within the ATP2A2 gene have been shown to be responsible for DD. 3 We report here clinical investigation and mutation spectrum of 8 families with DD and investigate phenotype-genotype correlation.
METHODS
Eight Tunisian families with a total of 23 patients and 9 unaffected family members were investigated. The diagnosis of DD was established based on clinical examination and confirmed by histopathologic findings.
After obtaining informed consent, skin biopsy and blood samples were collected from all participating members. Haplotype analysis was performed using microsatellite markers spanning the ATP2A2 region (D12S234, D12S1339, D12S2257, D12S1343, and D12S2263). Mutation screening of the ATP2A2 gene was performed by direct sequencing.
RESULTS
The investigated families had the classical DD phenotype. Skin lesions had started during early childhood and around puberty. Keratotic papules were observed on the face, neck, both axillae, and inframammary regions. The severity of the disease was not constant even among patients from the same family (Table) . One case was previously misdiagnosed as hidradenitis suppurativa, and several original clinical associations were observed. Among these, one patient presented with DD and pem-phigus vulgaris and another with congenital ichthyosis, diffuse alopecia, corneal opacity, mental retardation, and ovarian cancer.
Neuropsychiatric disorders were recorded in 5 families and included bipolar disorder type II, major depressive disorder, mental retardation, auditory and visual hallucinations, cyclothymic disorder, and social phobia. Although the investigated patients were from different genetic, environmental, and socioeconomic backgrounds, constant association with neuropsychiatric disorders suggests that the symptoms occur owing to a susceptibility locus that co-segregates with ATP2A2. 4 Linkage analysis to the ATP2A2 gene showed a haplotype heterogeneity that was confirmed by mutational screening. We identified 7 distinct mutations, among which 4 were novel (Table) . For only 1 family, no mutation was found; however, a rare variant of single nucleotide polymorphism (rs35235621) was identified.
The mutation spectrum identified herein included 3 heterozygous missense mutations (G217A, D702N, and L900R), one nonsense mutation (R677X), two frameshift deletions (1747-1749 del 2T and 119-120 delAG), and one frame-shift insertion (2772-2779 ins C). No clustering or mutation hot spots have been noted.
The novel missense mutations G217A and L900R result in nonconservative amino acid substitutions. The novel frame-shift mutations 1747-1749 del 2T and 2772-2779 ins C are expected to result in a loss of function. The novel variations have not been found in the 50 Tunisians of the control group.
COMMENT
Herein we report the results of our clinical and genetic investigation of DD in families of Tunisian national origin (of a total population of 10 million). Phenotypic variation was observed within and between the families, but none had severe DD. Mutational heterogeneity was also observed, owing to the richness of the genetic background. No obvious genotype-phenotype correlation was established. The neuropsychiatric disorders listed herein were not associated with a specific type of mutation and were not constant among affected members within the same family.
In conclusion, this study, the first to our knowledge regarding the incidence of DD in the North African population, gives further evidence for the clinical and mutational heterogeneity of DD worldwide. Differences in the expression of DD could be explained not only by environmental factors but also by modifier loci.
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